Catalyst Capital Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Catalyst Capital Advisors’s Portfolio MACK Stock Details MACK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell
2014 Q3	$569K	Buy
2014 Q2	$217K	Sell
2014 Q1	$1.92M	Buy
2013 Q4	$1.77M	Buy